Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase 1 Clinical study of Oravax's COVID-19 vaccine

Next Previous
X
Search
Trial Profile

Phase 1 Clinical study of Oravax's COVID-19 vaccine

Status: Recruiting
Phase of Trial: Phase I

Latest Information Update: 11 Oct 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs COVID-19 vaccine-Oravax Medical (Primary)
  • Indications COVID 2019 infections
  • Focus Adverse reactions; First in man; Proof of concept

    • Most Recent Events

    • 07 Oct 2022 Preliminary results (Cohort-1) presented in an Oramed Pharmaceuticals Media Release.
    • 07 Jul 2022 According to an Oramed Pharmaceuticals media release, the company expect Cohort B to complete dosing this quarter as well, with data expected in Q4 2022.
    • 07 Jul 2022 According to an Oramed Pharmaceuticals media release, due to several factors, including the fact that many volunteers did not qualify during screening due to prior asymptomatic COVID-19 infection and other conditions, the rate of enrollment was slower than anticipated. the company added an additional clinical site and we have since completed enrollment and dosing of Cohort A with no safety issues reported thus far and anticipate sharing top-line data this quarter.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top